Challenges in Evaluating and Standardizing Medical Devices in Health Care Facilities

Por Ventola, C. Lee
Publicado em 2008

President Obama’s Health Care Reform Policies: Issues of Interest to P&T Committees

Por Ventola, C. Lee
Publicado em 2009

Off-Label Drug Information: Regulation, Distribution, Evaluation, and Related Controversies

Por Ventola, C. Lee
Publicado em 2009

An Interview Series with Members of the ASHP Expert Panel on Formulary Management: Part 3: Sabrina W. Cole, PharmD

Por Ventola, C. Lee
Publicado em 2010

An Interview Series with Members of the ASHP Expert Panel on Formulary Management: Part 1: Linda S. Tyler, PharmD

Por Ventola, C. Lee
Publicado em 2009

An Interview Series with Members of the ASHP Expert Panel on Formulary Management: Part 2: J. Russell May, PharmD

Por Ventola, C. Lee
Publicado em 2009

Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States: Part 1: The Widespread Use of CAM and the Need for Better-Informed Health Care Professio...

Por Ventola, C. Lee
Publicado em 2010

Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States: Part 3: Policies and Practices Regarding Dietary Supplements In Health Care Facilities

Por Ventola, C. Lee
Publicado em 2010

Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States: Part 2: Regulatory and Safety Concerns and Proposed Governmental Policy Changes with Res...

Por Ventola, C. Lee
Publicado em 2010

Pharmacogenomics in Clinical Practice: Reality and Expectations

Por Ventola, C. Lee
Publicado em 2011

Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic?

Por Ventola, C. Lee
Publicado em 2011

The Drug Shortage Crisis in the United States: Causes, Impact, and Management Strategies

Por Ventola, C. Lee
Publicado em 2011

The Nanomedicine Revolution: Part 2: Current and Future Clinical Applications

Por Ventola, C. Lee
Publicado em 2012

The Nanomedicine Revolution: Part 1: Emerging Concepts

Por Ventola, C. Lee
Publicado em 2012

The Nanomedicine Revolution: Part 3: Regulatory and Safety Challenges

Por Ventola, C. Lee
Publicado em 2012

Biosimilars: Part 1: Proposed Regulatory Criteria for FDA Approval

Por Ventola, C. Lee
Publicado em 2013

Biosimilars: Part 2: Potential Concerns and Challenges for P&T Committees

Por Ventola, C. Lee
Publicado em 2013

Role of Pharmacogenomic Biomarkers In Predicting and Improving Drug Response: Part 1: The Clinical Significance of Pharmacogenetic Variants

Por Ventola, C. Lee
Publicado em 2013

The Role of Pharmacogenomic Biomarkers in Predicting and Improving Drug Response: Part 2: Challenges Impeding Clinical Implementation

Por Ventola, C. Lee
Publicado em 2013

Mobile Devices and Apps for Health Care Professionals: Uses and Benefits

Por Ventola, C. Lee
Publicado em 2014